Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesNeoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaRecruitingNot stated2026-09-03NCT07211178

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Tempus AI18

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Birmingham Hematology AssociatesBirminghamUnited States1
Cancer Care NorthwestSpokane ValleyUnited States5
Cancer Care Specialist of IllinoisO'FallonUnited States1
Cancer Care Specialist of RenoRenoUnited States1
Cleveland Clinic FloridaWestonUnited States58
Goshen Center for Cancer CareGoshenUnited States47
Gunderson HealthLa CrosseUnited States1
Nashville GeneralNashvilleUnited States1
Oncology Hematology AssociatesSpringfieldUnited States15
Pih Health Whittier HospitalWhittierUnited States4
Sanford - Sioux FallsSioux FallsUnited States1
Southern Illinois Hospital ServicesCarbondaleUnited States1
Summit Medical GroupFlorham ParkUnited States14
Trinity HealthAnn ArborUnited States1
University of Cincinnati Medical CenterCincinnatiUnited States83
UT Health HoustonHoustonUnited States14